Verduyn-van Weegen Felice Isabel
SEC insider (Form 3/4/5 filer). CIK 0002094941. Director at Agomab Therapeutics NV (AGMB) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 17, 2026. Located in PALO ALTO, CA.
Companies Verduyn-van Weegen Felice Isabel has filed insider reports for
- Agomab Therapeutics NV (AGMB): Director
- Evommune, Inc. (EVMN): Director, 10% Owner
Verduyn-van Weegen Felice Isabel
CIK: 0002094941
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
